Long-Term Effectiveness Of Omalizumab Treatment In Thai Severe Asthmatic Patients: A Real-Life Experience - 24/01/14
Doi : 10.1016/j.jaci.2013.12.029
Orapan Poachanukoon, Dr.MD 1, Theerasak Kawamatawong, Dr. 2, Atik Saengasapaviriya, Dr. 3, Chanchai Sittipunt, Dr. 4, Hiroshi Chantaphakul, Dr.MD, FAAAAI 5, Kittipong Maneechotesuwan, Prof. 6, Pintip Ngamchanyaporn, Dr. 7, Kunchit Piyavechviratana, Dr. 8, Apichart Khanisap, Dr. 9, Siwasak Juthong, Dr. 10, Warangkana Rithirak, Dr. 11, Chaicharn Pothirat, Dr. 12, Watchara Boonsawat, Dr. 13
1 Thammasat University, Pathumtani, Thailand
2 Ramathibodi Hospaital, Mahidol University, Taiwan
3 Phramonkutklao hospital, Thailand
4 Chulalongkorn University, Thailand
5 Chutuchak District, Chulalongkorn University Hospital, Bangkok, Thailand
6 Siriraj Hospital, Mahidol University, Bangkok, Thailand
7 Ramathibodi Hospaital, Mahidol University, Thailand
8 Pramongkut Hospital, Sathorn, Thailand
9 Thammasat University Hospital, Thailand
10 Faculty of Medicine, Songklanakrin University, Thailand
11 Songklanakarind University, Thailand
12 Chiangmai University, Thailand
13 Srinagarind Hospital, Thailand
5
Le texte complet de cet article est disponible en PDF.Plan
© 2014
Publié par Elsevier Masson SAS.
Vol 133 - N° 2S
P. AB2 - février 2014 Retour au numéro
Article précédent
- Effects of Budesonide/Formoterol (BUD/FM) Deliverd By Pressurized Metered-Dose Inhaler (pMDI) on Symptoms In African Americans and Caucasians With Moderate and Severe Asthma With and Without Fixed Airway Obstruction (FAO)
- Donald P. Tashkin, Bradley E. Chipps, Frank Trudo
- Role Of Monoclonal Antibody In Sickle Cell Disease Patients With Allergic Rhinitis and Asthma Along With Raised IgE Level
- Abdul Rehman Syed
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?